Researcher discovers mechanism to slow tumor growth and metastasis in breast cancer

by Cindy Young

(Medical Xpress)—Wright State University Boonshoft School of Medicine professor Julian Gomez-Cambronero, Ph.D., and his research team have discovered a key protein that plays a critical role in the development of breast cancer tumors and the spread of the disease to the nearby lungs.

Cambronero's findings, published this month in the leading cancer journal Oncogene (click here for the report), attribute the cancer's growth to a protein called Phospholipase D (PLD). Cambronero and his team found that by introducing two new of PLD they could shrink tumor growth and reduce subsequent metastasis by around 70 percent.

"Although it's still early to tell, the application of these inhibitors to research in human tissue is the next step that could lead to better, less toxic treatments in the battle against ," said Cambronero, a professor of biochemistry and molecular biology.

Breast cancer kills more women in the United States each year—about 40,000—than any other type of cancer, according to the National Cancer Institute. The disease strikes an estimated 232,340 females each year and 2,240 males.

Related Stories

Study finds new drug target for metastatic breast cancer

date Apr 11, 2013

Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the ...

Developmental protein plays role in spread of cancer

date Jun 14, 2013

A protein used by embryo cells during early development, and recently found in many different types of cancer, apparently serves as a switch regulating the spread of cancer, known as metastasis, report researchers ...

Recommended for you

Using healthy skin to identify cancer's origins

date 16 hours ago

Normal skin contains an unexpectedly high number of cancer-associated mutations, according to a study published in Science. The findings illuminate the first steps cells take towards becoming a cancer and de ...

Gender differences in receipt of end-of-life care

date 16 hours ago

(HealthDay)—There are gender differences in receipt of end-of-life (EoL) care among terminally ill cancer patients, with male patients more likely to receive intensive care unit (ICU) care, according to ...

Scientists unveil prostate cancer's 'Rosetta Stone'

date 18 hours ago

Almost 90 per cent of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs, a landmark new study reveals.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.